130 related articles for article (PubMed ID: 37254310)
1. In silico molecular study of hepatitis B virus X protein as a therapeutic target.
Hamadalnil Y; Altayb HN
J Biomol Struct Dyn; 2024 May; 42(8):4002-4015. PubMed ID: 37254310
[TBL] [Abstract][Full Text] [Related]
2. In Silico Molecular Docking and Simulation Studies of Protein HBx Involved in the Pathogenesis of Hepatitis B Virus-HBV.
Shaikh IA; Muddapur UM; C K; Badiger S; Kulkarni M; Mahnashi MH; Alshamrani SA; Huneif MA; More SS; Khan AA; Iqubal SMS
Molecules; 2022 Feb; 27(5):. PubMed ID: 35268612
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory activity of marine sponge metabolites on SARS-CoV-2 RNA dependent polymerase: virtual screening and molecular dynamics simulation.
Ali HSHM; Altayb HN; Firoz A; Bayoumi AAM; El Omri A; Chaieb K
J Biomol Struct Dyn; 2022; 40(20):10191-10202. PubMed ID: 34151745
[TBL] [Abstract][Full Text] [Related]
4. Virtual screening of natural inhibitors to the predicted HBx protein structure of Hepatitis B Virus using molecular docking for identification of potential lead molecules for liver cancer.
Pathak RK; Baunthiyal M; Taj G; Kumar A
Bioinformation; 2014; 10(7):428-35. PubMed ID: 25187683
[TBL] [Abstract][Full Text] [Related]
5. Structural Insights into the Interaction between the C-Terminal-Deleted BH3-like Motif Peptide of Hepatitis B Virus X Protein and Bcl-x
Kusunoki H; Sakamoto T; Kobayashi N; Kohno T; Wakamatsu K; Nagata T
Biochemistry; 2024 Mar; 63(5):632-643. PubMed ID: 38377677
[TBL] [Abstract][Full Text] [Related]
6. Molecular docking, molecular dynamics simulation and MM-GBSA studies of the activity of glycyrrhizin relevant substructures on SARS-CoV-2 RNA-dependent-RNA polymerase.
Zamzami MA
J Biomol Struct Dyn; 2023 Mar; 41(5):1846-1858. PubMed ID: 35037842
[TBL] [Abstract][Full Text] [Related]
7. Emetine, a potent alkaloid for the treatment of SARS-CoV-2 targeting papain-like protease and non-structural proteins: pharmacokinetics, molecular docking and dynamic studies.
Snoussi M; Redissi A; Mosbah A; De Feo V; Adnan M; Aouadi K; Alreshidi M; Patel M; Kadri A; Noumi E
J Biomol Struct Dyn; 2022; 40(20):10122-10135. PubMed ID: 34254564
[TBL] [Abstract][Full Text] [Related]
8. Assessing the inhibitory potential of anti-dengue compounds against Japanese encephalitis virus RNA dependent RNA polymerase: an in silico study.
Bajrai LH; Alandijany TA; Alsaady I; El-Daly MM; Tolah AM; Khateb AM; Dubey A; Dwivedi VD; Azhar EI
J Biomol Struct Dyn; 2023 Oct; ():1-17. PubMed ID: 37811742
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus X protein-elevated MSL2 modulates hepatitis B virus covalently closed circular DNA by inducing degradation of APOBEC3B to enhance hepatocarcinogenesis.
Gao Y; Feng J; Yang G; Zhang S; Liu Y; Bu Y; Sun M; Zhao M; Chen F; Zhang W; Ye L; Zhang X
Hepatology; 2017 Nov; 66(5):1413-1429. PubMed ID: 28608964
[TBL] [Abstract][Full Text] [Related]
10. Effect of temperature on hepatitis a virus and exploration of binding mode mechanism of phytochemicals from
Moharana M; Maharana PC; Pattanayak SK; Khan F
J Biomol Struct Dyn; 2024; 42(2):598-614. PubMed ID: 36995189
[TBL] [Abstract][Full Text] [Related]
11. Construction of a HIV-1 subtype C 3D model using homology modeling and in-silico docking, molecular dynamics simulation, and MM-GBSA calculation of second-generation HIV-1 maturation inhibitor(s).
K C Y; Pal S; Nitz TJ; Wild C; Gaur R
J Biomol Struct Dyn; 2023 Jul; ():1-10. PubMed ID: 37489057
[TBL] [Abstract][Full Text] [Related]
12. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
[TBL] [Abstract][Full Text] [Related]
13. Computational Evaluation of Abrogation of HBx-Bcl-xL Complex with High-Affinity Carbon Nanotubes (Fullerene) to Halt the Hepatitis B Virus Replication.
Khan A; Ahsan O; Wei DQ; Ansari JK; Najmi MH; Muhammad K; Waheed Y
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770842
[TBL] [Abstract][Full Text] [Related]
14. 14-3-3ΞΆ binds to hepatitis B virus protein X and maintains its protein stability in hepatocellular carcinoma cells.
Tang Y; Zhang Y; Wang C; Sun Z; Li L; Dong J; Zhou W
Cancer Med; 2018 Nov; 7(11):5543-5553. PubMed ID: 30358169
[TBL] [Abstract][Full Text] [Related]
15. Discovery of phyto-compounds as novel inhibitors against
Kar B; Kundu CN; Pati S; Bhattacharya D
J Biomol Struct Dyn; 2023 Mar; 41(4):1267-1280. PubMed ID: 34961397
[TBL] [Abstract][Full Text] [Related]
16. Antiviral Compounds Screening Targeting HBx Protein of the Hepatitis B Virus.
Ma Y; Nakamoto S; Ao J; Qiang N; Kogure T; Ogawa K; Nakagawa M; Fujiwara K; Iwanaga T; Kojima R; Kanzaki H; Koroki K; Kobayashi K; Kanogawa N; Kiyono S; Nakamura M; Kondo T; Nakagawa R; Ogasawara S; Muroyama R; Chiba T; Kato J; Kato N
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233317
[TBL] [Abstract][Full Text] [Related]
17.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
18. In silico screening of the effectiveness of natural compounds from algae as SARS-CoV-2 inhibitors: molecular docking, ADMT profile and molecular dynamic studies.
Mohammed Ali HSH; Altayb HN; Bayoumi AAM; El Omri A; Firoz A; Chaieb K
J Biomol Struct Dyn; 2023 Apr; 41(7):3129-3144. PubMed ID: 35253618
[TBL] [Abstract][Full Text] [Related]
19. Interaction of the hepatitis B virus X protein with the lysine methyltransferase SET and MYND domain-containing 3 induces activator protein 1 activation.
Hayashi M; Deng L; Chen M; Gan X; Shinozaki K; Shoji I; Hotta H
Microbiol Immunol; 2016 Jan; 60(1):17-25. PubMed ID: 26616333
[TBL] [Abstract][Full Text] [Related]
20. Computational investigation of phytoalexins as potential antiviral RAP-1 and RAP-2 (Replication Associated Proteins) inhibitor for the management of cucumber mosaic virus (CMV): a molecular modeling,
Mohan Kumar R; Anantapur R; Peter A; H V C
J Biomol Struct Dyn; 2022; 40(22):12165-12183. PubMed ID: 34463218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
